Evaluation of Non-HDL Cholesterol and Total Cholesterol/HDL-C Ratio, LDL-C/HDL-C Ratio as Cumulative Marker of Cardiovascular Disease risk in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.7439/ijbr.v7i9.3593Keywords:
myaesthenia gravis, autoimune disorder, statin therapyAbstract
Background: Cardiovascular disease (CVD) is the leading cause of death worldwide with an estimated 17.3 million deaths from CVDs in 2008, representing 30% of all global deaths. The main cause of CVD development is atherosclerosis and among the various factors for developing increased cardiovascular risk in diabetes; lipid abnormalities, the dyslipidemia is the major contributor. The common type of dyslipidemia in diabetes is characterized by elevated triglyceride (TG), low levels of high density lipoprotein cholesterol (HDL-C) and typically has a preponderance of smaller, denser low density lipoprotein cholesterol (LDL-C) particles, which possibly increases atherogenicity even if the absolute concentration of LDL cholesterol (LDL-C) is not significantly increased. Materials and Methods: Total of 100 diagnosed type 2 diabetes mellitus ambulatory patients of both sexes were taken as cases. Their age ranged between 30 to 70 years. 100 healthy subjects, with their age ranging between 30 to 70 years were selected as control group. Serum sample was used for the estimation of study parameters such as FBS, PPBS, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol. Results: In this study, total cholesterol, triglycerides, LDL-C, Non-HDL-C, TC/HDL-C and LDL-C/HDL-C were found to be statistically significantly increased in type 2 diabetes mellitus patients when compared to controls. HDL-C was significantly decreased in type 2 diabetes mellitus patients when compared to controls ( p -value 0.001). Conclusion: In this study, type 2 diabetes mellitus is associated with dyslipidemia with increased levels of TC, TG, LDL-C, Non-HDL-C, TC/HDL-C and LDL-C/HDL-C ratio, but a lower levels of HDL-C compared to that of controls. Increased levels of Non-HDL-C, TC/HDL-C and LDL-C/HDL-C ratio which indicates increased impending cardiovascular disease risk in type 2 diabetes mellitus.Downloads
References
Chowdhury S, Chowdhury JR and Goswami S. The Importance of Non High Density Lipoprotein Cholesterol in Dyslipidemia Management. Diabetes & Metabolism. J Diabetes Metab 2015; 6 (11):1-5.
Chauhan S, Aeri BT, Prevalence of cardiovascular disease in India and its economic impact-A review. International Journal of Scientific and Research Publications. 2013; 3 (10):1-5.
Aryl M, PoudelA, Satyal B, Gyawali P, Pokheral BR, Raut Bk et al., Evaluation of non-HDLC and total cholesterol: HDLC ratio as cumulative marker of cardiovascular risk in diabetes mellitus. Kathmandu University Medical Journal. 2010; 9(32):398-404.
Weiquan lu, Jain AK, Resnick HE, Howard WJ, Jablonski KA, Robbins DC et al., Non-HDL Cholesterol as a predictor of cardiovascular disease in type 2 diabetes. Diabetes Care. 2003; 26(1):16-23.
A Pandeya, Sharma M, Regmi P, Basukala A and Lamsal M. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus. Nepal medical College Journal. 2012; 14(4):278-282.
Kondru S, Thakur A. Role of Non-HDL Cholesterol and LDLc/HDLc ratio to assess cardiovascular risk in type II diabetes patients. International Research Journal of Medical Sciences. 2015; 3(1):23-28.
Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR and Kinosian B. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med. 2003; 25:50-57.
Wilson PW, High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 1990; 66(6)7A-10A.
Sapna Smith and Alok M Lall. A study on lipid profile levels of diabetics and non-diabetics among Naini region of Allahabad, India. Turkish Journal of Biochemistry. 2008; 33(4):138-141.
Mooradian AD et al, Obesity-related changes in high-density lipoprotein metabolism. Obesity. 2008; 16:1152-1160.
Indumathi V, Patil VS, Krishnaswamy D et al., Non-HDL cholesterol and LDLC/HDLC ratio in type 2 diabetic patients. Int J Pharm Bio Sci.2011; 2:71-77.
Bittner V. Non-HDL Cholesterol: Measurement, interpretation and significance. John Hopkins Advance Studies Med. 2007; 7:8-11.
Peters AL. Clinical relevance of Non-HDL cholesterol in patients with diabetes. Clin Diabtes. 2008; 26:3-7.
Grundy SM. Low-density lipoprotein, non-high-density lipoprotein and apolipoprotein B as targets of lipid-lowering therapy. Circulation. 2002; 285:2486-2497.
American Diabetes Association: Dyslipidemia management in adults with diabetes. Diabetes Care. 2004; 27:S68-S71.
Duewell P, Kono H, Rayner KJ, Sirois Cm, Vladimer G et al.,NLRP3 inflammasomes are required for atherogenesis aand activated by cholesterol crystals. Nature. 2010; 464:1357-1361.
Grundy SM, Vega GL, Tomassini JE, tershakovec AM. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial). Am J Cardiol. 2009; 104:548-553.
Wei fen Zhu, Liang L, Wang CL and fen FU J. Triglyceride and Non-High-Density-Lipoprotein Cholesterol as Predictors of Cardiovascular Disease Risk Factors in Chinese Han Children. Indian Pediatrics. 2013; 50:394-398.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.